Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
300 studies found for:    HIV [CONDITION] AND ((anti-hiv OR antiretroviral) AND medicines) [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Unknown  Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
22 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
Condition: HIV Infections
Interventions: Drug: lopinavir;   Drug: atazanavir;   Drug: efavirenz;   Drug: fosamprenavir;   Drug: darunavir;   Drug: tipranavir;   Drug: ritonavir;   Drug: nevirapine;   Drug: zidovudine;   Drug: lamivudine;   Drug: tenofovir;   Drug: emtricitabine;   Drug: abacavir
23 Recruiting Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
Condition: HIV
Interventions: Drug: Dolutegravir;   Drug: Emtricitabine/Tenofovir
24 Recruiting Research In Viral Eradication of HIV Reservoirs
Condition: HIV
Interventions: Drug: Combination Antiretroviral Therapy (cART);   Drug: Raltegravir;   Drug: Vorinostat;   Biological: ChAdV63.HIVconsv (ChAd);   Biological: MVA.HIVconsv (MVA)
25 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
26 Recruiting Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
Conditions: Tuberculosis;   HIV
Interventions: Drug: 8 hourly LPV/r during TB treatment;   Drug: Nevirapine;   Drug: Lopinavir/Ritonavir
27 Recruiting Dolutegravir in Reservoirs
Condition: HIV
Interventions: Drug: dolutegravir;   Drug: Triumeq;   Drug: Truvada
28 Unknown  A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients
Condition: HIV
Intervention: Drug: Zidovudine (drug)
29 Recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT);   Drug: Dasabuvir (DSV);   Drug: Ribavirin (RBV)
30 Recruiting Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Bedaquiline;   Drug: Delamanid;   Drug: Dolutegravir
31 Recruiting HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection
Conditions: Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: E/C/F/TAF;;   Drug: Ledipasvir-Sofosbuvir
32 Recruiting Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults
Condition: HIV-1 Infection
Interventions: Drug: E/C/F/TAF;   Drug: ABC/3TC;   Drug: Third Antiretroviral Agent
33 Not yet recruiting Early ART to Limit Infection and Establishment of Reservoir
Condition: HIV-1 Infection
Intervention: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
34 Unknown  HIV Antiretroviral Drugs and Metabolism
Condition: HIV Infections
Intervention: Drug: ritonavir, lopinavir/ritonavir, atazanavir/ritonavir, efavirenz
35 Recruiting Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals
Condition: HIV
Intervention: Drug: Enfuvirtide
36 Recruiting Effect of Cenicriviroc on HIV Neurocognitive Impairment
Conditions: AIDS Dementia Complex;   HIV-1-Associated Cognitive Motor Complex;   Human Immunodeficiency Virus
Intervention: Drug: cenicriviroc
37 Recruiting Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy
Condition: HIV/AIDS
38 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
39 Unknown  High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
Conditions: HIV;   AIDS
Intervention: Drug: Kaletra (drug)
40 Unknown  Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Nelfinavir

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years